e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Respiratory epidemiology: methods, definitions and phenotypes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Definition and validation of a predictive model to identify COPD patients from administrative databases
L. Bauleo, N. Agabiti, U. Kirchmayer, V. Belleudi, L. Pinnarelli, S. Cascini, D. Fusco, M. Arcà, M. Davoli (Rome, Italy)
Source:
Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Session:
Respiratory epidemiology: methods, definitions and phenotypes
Session type:
Thematic Poster Session
Number:
4158
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Bauleo, N. Agabiti, U. Kirchmayer, V. Belleudi, L. Pinnarelli, S. Cascini, D. Fusco, M. Arcà, M. Davoli (Rome, Italy). Definition and validation of a predictive model to identify COPD patients from administrative databases. Eur Respir J 2011; 38: Suppl. 55, 4158
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
A general framework to implement predictive models for hospitalizations: Application to COPD
Source: International Congress 2017 – Best abstracts in the management of chronic respiratory diseases
Year: 2017
Developing a claims’-based algorithm to identify US patients with COPD
Source: International Congress 2019 – More and more COPD
Year: 2019
Detecting undiagnosed COPD: Using routine primary care data to select and validate candidate variables for COPD risk prediction
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013
Validation of asthma diagnostic codes in the administrative health databases of Québec, Canada
Source: Eur Respir J 2004; 24: Suppl. 48, 597s
Year: 2004
Clinical COPD phenotypes identified by cluster analysis: validation with mortality
Source: Eur Respir J 2012; 40: 495-496
Year: 2012
Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014
Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Clinical features and functional parameters predict the probability of ACO in patients with asthma and COPD
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
A predictive model for classifying COPD patients according to CT emphysema extent by using functional data and BMI
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017
Self-reported COPD: spirometric validation in a resource limited setting
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008
Design and assessment of an automated prediction model for 30-day re-hospitalization after a COPD exacerbation using genetic algorithms
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019
Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index.
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
External validation of the updated ADO score to predict mortality in COPD patients from the Birmingham COPD cohort
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019
Clinical phenotyping of COPD patients: a simple tool with prognosis value
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
Clinical prognostic tools and their use in COPD.
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
External validation of the French predictive model to estimate PAH survival: A REVEAL analysis
Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries
Year: 2012
Prediction of one or two years’ exacerbation free time in primary care COPD patients, a validated prediction nomogram
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017
The validation of the COPD screening questionnaires and establishment for the detection of COPD subjects in the general medical check-up setting.
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019
The evaluation of a tele-monitoring model (Teleheath) as an aid in the case management of patients with COPD
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012
External validation of two prognostic scores predicting exacerbations in ECLIPSE COPD patients
Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept